Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy, Safety and Neural Mechanism of Stellate Ganglion Block in the Treatment of Anxiety.

NCT06540313 is registered in ClinicalTrials.gov with Nanjing Medical University as lead sponsor.

NCT NCT06540313
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06540313 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy, Safety and Neural Mechanism of Stellate Ganglion Block in the Treatment of Anxiety.
Lead sponsor
Nanjing Medical University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 1, 2024
Completion date
June 10, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety disorders, stellate ganglion block